Article Details
Retrieved on: 2021-05-17 13:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The brokerage currently has an "overweight" rating on the biotechnology company's stock. Morgan Stanley's price objective suggests a potential upside ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here